共 130 条
- [21] Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO
- [22] 2-E
- [24] Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis - A randomized, double-blind, placebo-controlled, dose-escalation trial [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (12): : 3143 - 3150
- [25] LOCALIZATION OF TUMOR-NECROSIS-FACTOR-ALPHA IN SYNOVIAL TISSUES AND AT THE CARTILAGE PANNUS JUNCTION IN PATIENTS WITH RHEUMATOID-ARTHRITIS [J]. ARTHRITIS AND RHEUMATISM, 1991, 34 (09): : 1125 - 1132
- [26] Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (05): : 1299 - 1309
- [30] LOCALIZATION OF TUMOR-NECROSIS-FACTOR RECEPTORS IN THE SYNOVIAL TISSUE AND CARTILAGE PANNUS JUNCTION IN PATIENTS WITH RHEUMATOID-ARTHRITIS - IMPLICATIONS FOR LOCAL ACTIONS OF TUMOR-NECROSIS-FACTOR-ALPHA [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (10): : 1170 - 1178